- Report
- April 2025
- 175 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- February 2025
- 200 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- April 2025
- 175 Pages
Global
From €3975EUR$4,490USD£3,443GBP
- Report
- June 2025
- 400 Pages
Global
From €4382EUR$4,949USD£3,795GBP
- Report
- January 2024
- 150 Pages
Global
From €2877EUR$3,250USD£2,492GBP
€4294EUR$4,850USD£3,719GBP
- Report
- September 2021
- 99 Pages
Global
From €3984EUR$4,500USD£3,451GBP
- Report
- July 2023
- 145 Pages
Global
From €2789EUR$3,150USD£2,415GBP
- Report
- May 2023
- 74 Pages
Global
From €3500EUR$4,235USD£3,137GBP
- Drug Pipelines
- November 2020
- 35 Pages
Global
From €1771EUR$2,000USD£1,534GBP
- Report
- December 2023
- 300 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- December 2023
- 80 Pages
Russia
From €1328EUR$1,500USD£1,150GBP
- Report
- December 2023
- 80 Pages
Poland
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 300 Pages
Global
From €2213EUR$2,500USD£1,917GBP
- Report
- October 2023
- 100 Pages
Africa
From €1771EUR$2,000USD£1,534GBP
- Report
- October 2023
- 80 Pages
United States
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
United Kingdom
From €1328EUR$1,500USD£1,150GBP
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
South Korea
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
Saudi Arabia
From €1328EUR$1,500USD£1,150GBP
- Report
- October 2023
- 80 Pages
India
From €1328EUR$1,500USD£1,150GBP

Liothyronine is a synthetic form of the thyroid hormone triiodothyronine (T3). It is used to treat hypothyroidism, a condition in which the thyroid gland does not produce enough thyroid hormone. It is also used to treat goiter, an enlarged thyroid gland, and to treat thyroid cancer. Liothyronine is a part of the Endocrine and Metabolic Disorders Drugs market, which includes drugs used to treat a variety of conditions related to hormones and metabolism. These drugs are used to treat conditions such as diabetes, obesity, and thyroid disorders.
Liothyronine is available in both brand-name and generic forms. It is available as a tablet, capsule, and liquid solution. It is usually taken once a day, but the dosage and frequency may vary depending on the patient's condition.
Companies in the Liothyronine market include AbbVie, Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more